Cargando…
Urine markers and prostate cancer
Prostate cancer (PCa) is globally the most common cancer in men, with an estimated prevalence of more than two million cases. Given the poor success rate in treating advanced PCa, intervention in early stages may reduce the progression of a small, localized carcinoma to a large metastatic lesion, th...
Autores principales: | Wilkosz, Jacek, Bryś, Magdalena, Różański, Waldemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921702/ https://www.ncbi.nlm.nih.gov/pubmed/24578853 http://dx.doi.org/10.5173/ceju.2011.01.art2 |
Ejemplares similares
-
Relationship of urinary isoprostanes to prostate cancer occurence
por: Brys, Magdalena, et al.
Publicado: (2012) -
Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance—promising for molecular staging of prostate cancers
por: Bryś, Magdalena, et al.
Publicado: (2013) -
Complication rates after prostate biopsy according to the number of sampled cores
por: Madej, Adam, et al.
Publicado: (2012) -
HIF-1, GLUT1, endoglin, and BIRC5 expression in urine samples obtained from patients with bladder malignancies – after photodynamic diagnosis (PDD)
por: Markowski, Michał, et al.
Publicado: (2012) -
The calpain system as a potential target for pelvic muscle reinforcement
por: Blewniewski, Mariusz, et al.
Publicado: (2011)